These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3734404)

  • 1. Prenatal determination of obesity, tumor susceptibility, and coat color pattern in viable yellow (Avy/a) mice. The yellow mouse syndrome.
    Wolff GL; Roberts DW; Galbraith DB
    J Hered; 1986; 77(3):151-8. PubMed ID: 3734404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic glutathione S-transferase activity in mice: effects of Avy/-genotype, obesity, lindane treatment, and sex.
    Wolff GL; Suber RL
    Proc Soc Exp Biol Med; 1986 Apr; 181(4):535-41. PubMed ID: 2419915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumorigenic responses to lindane in mice: potentiation by a dominant mutation.
    Wolff GL; Roberts DW; Morrissey RL; Greenman DL; Allen RR; Campbell WL; Bergman H; Nesnow S; Frith CH
    Carcinogenesis; 1987 Dec; 8(12):1889-97. PubMed ID: 2445499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response effects of ectopic agouti protein on iron overload and age-associated aspects of the Avy/a obese mouse phenome.
    Wolff GL; Whittaker P
    Peptides; 2005 Oct; 26(10):1697-711. PubMed ID: 15982784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phaeomelanin synthesis and obesity in mice. Interaction of the viable yellow (Avy) and sombre (eso) mutations.
    Wolff GL; Galbraith DB; Domon OE; Row JM
    J Hered; 1978; 69(5):295-8. PubMed ID: 744871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the mottled yellow and pseudoagouti phenotypes on immunocompetence in Avy/a mice.
    Roberts DW; Wolff GL; Campbell WL
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2152-6. PubMed ID: 6609359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice.
    Wolff GL; Kodell RL; Moore SR; Cooney CA
    FASEB J; 1998 Aug; 12(11):949-57. PubMed ID: 9707167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple levels of response in carcinogenicity bioassays: regulational variation among viable yellow (Avy/-) mice.
    Wolff GL
    J Exp Anim Sci; 1993 Sep; 35(5-6):221-31. PubMed ID: 8218437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soy protein isolate reduces hepatosteatosis in yellow Avy/a mice without altering coat color phenotype.
    Badger TM; Ronis MJ; Wolff G; Stanley S; Ferguson M; Shankar K; Simpson P; Jo CH
    Exp Biol Med (Maywood); 2008 Oct; 233(10):1242-54. PubMed ID: 18791133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of age and obesity on the metabolism of lindane by black a/a, yellow Avy/a, and pseudoagouti Avy/a phenotypes of (YS x VY) F1 hybrid mice.
    Chadwick RW; Copeland MF; Wolff GL; Cooke N; Whitehouse DA; Mole ML
    J Toxicol Environ Health; 1985; 16(6):771-96. PubMed ID: 2419580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene.
    Yen TT; Gill AM; Frigeri LG; Barsh GS; Wolff GL
    FASEB J; 1994 May; 8(8):479-88. PubMed ID: 8181666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur.
    Klebig ML; Wilkinson JE; Geisler JG; Woychik RP
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4728-32. PubMed ID: 7761391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of maternal phenotype on metabolic differentiation of agouti locus mutants in the mouse.
    Wolff GL
    Genetics; 1978 Mar; 88(3):529-39. PubMed ID: 640377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of response to insulin and anti-insulin action by two human pituitary peptides in lean agouti A/a, obese yellow Avy/A, and C57BL/6J-ob/ob mice.
    Salem MA; Wolff GL
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):113-23. PubMed ID: 2657747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal MSG reduces hypothalamic DA, beta-endorphin, and delays weight gain in genetically obese (A viable yellow/alpha) mice.
    Caputo FA; Ali SF; Wolff GL; Scallet AC
    Pharmacol Biochem Behav; 1996 Feb; 53(2):425-32. PubMed ID: 8808153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential spontaneous transformation in vitro of newly established mouse fibroblast lines carrying or lacking the viable yellow mutation (Avy) of the mouse agouti locus.
    Hsiao WL; Wolff GL; North BM; Ollmann MM; Barsh GS; Fan H
    Mol Carcinog; 1996 Jan; 15(1):70-80. PubMed ID: 8561869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular basis for dominant yellow agouti coat color mutations.
    Perry WL; Copeland NG; Jenkins NA
    Bioessays; 1994 Oct; 16(10):705-7. PubMed ID: 7980472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity as a pleiotropic effect of gene action.
    Wolff GL
    J Nutr; 1997 Sep; 127(9):1897S-1901S. PubMed ID: 9278578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver-specific expression of the agouti gene in transgenic mice promotes liver carcinogenesis in the absence of obesity and diabetes.
    Kuklin AI; Mynatt RL; Klebig ML; Kiefer LL; Wilkison WO; Woychik RP; Michaud EJ
    Mol Cancer; 2004 Jun; 3():17. PubMed ID: 15175105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome.
    Dolinoy DC; Weidman JR; Waterland RA; Jirtle RL
    Environ Health Perspect; 2006 Apr; 114(4):567-72. PubMed ID: 16581547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.